Global NGS-based RNA-seq Market Research Report 2024(Status and Outlook)
Report Overview:
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The Global NGS-based RNA-seq Market Size was estimated at USD 1768.19 million in 2023 and is projected to reach USD 3361.24 million by 2029, exhibiting a CAGR of 11.30% during the forecast period.
This report provides a deep insight into the global NGS-based RNA-seq market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global NGS-based RNA-seq Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the NGS-based RNA-seq market in any manner.
Global NGS-based RNA-seq Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Market Segmentation (by Type)
High-Throughput Sequencing
Third-Generation Sequencing Technology
Market Segmentation (by Application)
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-based RNA-seq Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The Global NGS-based RNA-seq Market Size was estimated at USD 1768.19 million in 2023 and is projected to reach USD 3361.24 million by 2029, exhibiting a CAGR of 11.30% during the forecast period.
This report provides a deep insight into the global NGS-based RNA-seq market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global NGS-based RNA-seq Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the NGS-based RNA-seq market in any manner.
Global NGS-based RNA-seq Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Market Segmentation (by Type)
High-Throughput Sequencing
Third-Generation Sequencing Technology
Market Segmentation (by Application)
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the NGS-based RNA-seq Market
- Overview of the regional outlook of the NGS-based RNA-seq Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-based RNA-seq Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of NGS-based RNA-seq
1.2 Key Market Segments
1.2.1 NGS-based RNA-seq Segment by Type
1.2.2 NGS-based RNA-seq Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NGS-BASED RNA-SEQ MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NGS-based RNA-seq Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global NGS-based RNA-seq Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NGS-BASED RNA-SEQ MARKET COMPETITIVE LANDSCAPE
3.1 Global NGS-based RNA-seq Sales by Manufacturers (2019-2024)
3.2 Global NGS-based RNA-seq Revenue Market Share by Manufacturers (2019-2024)
3.3 NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global NGS-based RNA-seq Average Price by Manufacturers (2019-2024)
3.5 Manufacturers NGS-based RNA-seq Sales Sites, Area Served, Product Type
3.6 NGS-based RNA-seq Market Competitive Situation and Trends
3.6.1 NGS-based RNA-seq Market Concentration Rate
3.6.2 Global 5 and 10 Largest NGS-based RNA-seq Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NGS-BASED RNA-SEQ INDUSTRY CHAIN ANALYSIS
4.1 NGS-based RNA-seq Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NGS-BASED RNA-SEQ MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NGS-based RNA-seq Sales Market Share by Type (2019-2024)
6.3 Global NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
6.4 Global NGS-based RNA-seq Price by Type (2019-2024)
7 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NGS-based RNA-seq Market Sales by Application (2019-2024)
7.3 Global NGS-based RNA-seq Market Size (M USD) by Application (2019-2024)
7.4 Global NGS-based RNA-seq Sales Growth Rate by Application (2019-2024)
8 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY REGION
8.1 Global NGS-based RNA-seq Sales by Region
8.1.1 Global NGS-based RNA-seq Sales by Region
8.1.2 Global NGS-based RNA-seq Sales Market Share by Region
8.2 North America
8.2.1 North America NGS-based RNA-seq Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe NGS-based RNA-seq Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific NGS-based RNA-seq Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America NGS-based RNA-seq Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa NGS-based RNA-seq Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina NGS-based RNA-seq Basic Information
9.1.2 Illumina NGS-based RNA-seq Product Overview
9.1.3 Illumina NGS-based RNA-seq Product Market Performance
9.1.4 Illumina Business Overview
9.1.5 Illumina NGS-based RNA-seq SWOT Analysis
9.1.6 Illumina Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific NGS-based RNA-seq Basic Information
9.2.2 Thermo Fisher Scientific NGS-based RNA-seq Product Overview
9.2.3 Thermo Fisher Scientific NGS-based RNA-seq Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific NGS-based RNA-seq SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 Pacific Biosciences Of California
9.3.1 Pacific Biosciences Of California NGS-based RNA-seq Basic Information
9.3.2 Pacific Biosciences Of California NGS-based RNA-seq Product Overview
9.3.3 Pacific Biosciences Of California NGS-based RNA-seq Product Market Performance
9.3.4 Pacific Biosciences Of California NGS-based RNA-seq SWOT Analysis
9.3.5 Pacific Biosciences Of California Business Overview
9.3.6 Pacific Biosciences Of California Recent Developments
9.4 Qaigen
9.4.1 Qaigen NGS-based RNA-seq Basic Information
9.4.2 Qaigen NGS-based RNA-seq Product Overview
9.4.3 Qaigen NGS-based RNA-seq Product Market Performance
9.4.4 Qaigen Business Overview
9.4.5 Qaigen Recent Developments
9.5 F. Hoffmann-La Roche
9.5.1 F. Hoffmann-La Roche NGS-based RNA-seq Basic Information
9.5.2 F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
9.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Product Market Performance
9.5.4 F. Hoffmann-La Roche Business Overview
9.5.5 F. Hoffmann-La Roche Recent Developments
9.6 Agilent Technologies
9.6.1 Agilent Technologies NGS-based RNA-seq Basic Information
9.6.2 Agilent Technologies NGS-based RNA-seq Product Overview
9.6.3 Agilent Technologies NGS-based RNA-seq Product Market Performance
9.6.4 Agilent Technologies Business Overview
9.6.5 Agilent Technologies Recent Developments
9.7 Oxford Nanopore Technologies
9.7.1 Oxford Nanopore Technologies NGS-based RNA-seq Basic Information
9.7.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
9.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Product Market Performance
9.7.4 Oxford Nanopore Technologies Business Overview
9.7.5 Oxford Nanopore Technologies Recent Developments
9.8 Perkinelmer
9.8.1 Perkinelmer NGS-based RNA-seq Basic Information
9.8.2 Perkinelmer NGS-based RNA-seq Product Overview
9.8.3 Perkinelmer NGS-based RNA-seq Product Market Performance
9.8.4 Perkinelmer Business Overview
9.8.5 Perkinelmer Recent Developments
9.9 Eurofins Scientific
9.9.1 Eurofins Scientific NGS-based RNA-seq Basic Information
9.9.2 Eurofins Scientific NGS-based RNA-seq Product Overview
9.9.3 Eurofins Scientific NGS-based RNA-seq Product Market Performance
9.9.4 Eurofins Scientific Business Overview
9.9.5 Eurofins Scientific Recent Developments
9.10 Gatc Biotech
9.10.1 Gatc Biotech NGS-based RNA-seq Basic Information
9.10.2 Gatc Biotech NGS-based RNA-seq Product Overview
9.10.3 Gatc Biotech NGS-based RNA-seq Product Market Performance
9.10.4 Gatc Biotech Business Overview
9.10.5 Gatc Biotech Recent Developments
9.11 Macrogen
9.11.1 Macrogen NGS-based RNA-seq Basic Information
9.11.2 Macrogen NGS-based RNA-seq Product Overview
9.11.3 Macrogen NGS-based RNA-seq Product Market Performance
9.11.4 Macrogen Business Overview
9.11.5 Macrogen Recent Developments
10 NGS-BASED RNA-SEQ MARKET FORECAST BY REGION
10.1 Global NGS-based RNA-seq Market Size Forecast
10.2 Global NGS-based RNA-seq Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe NGS-based RNA-seq Market Size Forecast by Country
10.2.3 Asia Pacific NGS-based RNA-seq Market Size Forecast by Region
10.2.4 South America NGS-based RNA-seq Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of NGS-based RNA-seq by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global NGS-based RNA-seq Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of NGS-based RNA-seq by Type (2025-2030)
11.1.2 Global NGS-based RNA-seq Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of NGS-based RNA-seq by Type (2025-2030)
11.2 Global NGS-based RNA-seq Market Forecast by Application (2025-2030)
11.2.1 Global NGS-based RNA-seq Sales (K Units) Forecast by Application
11.2.2 Global NGS-based RNA-seq Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of NGS-based RNA-seq
1.2 Key Market Segments
1.2.1 NGS-based RNA-seq Segment by Type
1.2.2 NGS-based RNA-seq Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NGS-BASED RNA-SEQ MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NGS-based RNA-seq Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global NGS-based RNA-seq Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NGS-BASED RNA-SEQ MARKET COMPETITIVE LANDSCAPE
3.1 Global NGS-based RNA-seq Sales by Manufacturers (2019-2024)
3.2 Global NGS-based RNA-seq Revenue Market Share by Manufacturers (2019-2024)
3.3 NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global NGS-based RNA-seq Average Price by Manufacturers (2019-2024)
3.5 Manufacturers NGS-based RNA-seq Sales Sites, Area Served, Product Type
3.6 NGS-based RNA-seq Market Competitive Situation and Trends
3.6.1 NGS-based RNA-seq Market Concentration Rate
3.6.2 Global 5 and 10 Largest NGS-based RNA-seq Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NGS-BASED RNA-SEQ INDUSTRY CHAIN ANALYSIS
4.1 NGS-based RNA-seq Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NGS-BASED RNA-SEQ MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NGS-based RNA-seq Sales Market Share by Type (2019-2024)
6.3 Global NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
6.4 Global NGS-based RNA-seq Price by Type (2019-2024)
7 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NGS-based RNA-seq Market Sales by Application (2019-2024)
7.3 Global NGS-based RNA-seq Market Size (M USD) by Application (2019-2024)
7.4 Global NGS-based RNA-seq Sales Growth Rate by Application (2019-2024)
8 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY REGION
8.1 Global NGS-based RNA-seq Sales by Region
8.1.1 Global NGS-based RNA-seq Sales by Region
8.1.2 Global NGS-based RNA-seq Sales Market Share by Region
8.2 North America
8.2.1 North America NGS-based RNA-seq Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe NGS-based RNA-seq Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific NGS-based RNA-seq Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America NGS-based RNA-seq Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa NGS-based RNA-seq Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina NGS-based RNA-seq Basic Information
9.1.2 Illumina NGS-based RNA-seq Product Overview
9.1.3 Illumina NGS-based RNA-seq Product Market Performance
9.1.4 Illumina Business Overview
9.1.5 Illumina NGS-based RNA-seq SWOT Analysis
9.1.6 Illumina Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific NGS-based RNA-seq Basic Information
9.2.2 Thermo Fisher Scientific NGS-based RNA-seq Product Overview
9.2.3 Thermo Fisher Scientific NGS-based RNA-seq Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific NGS-based RNA-seq SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 Pacific Biosciences Of California
9.3.1 Pacific Biosciences Of California NGS-based RNA-seq Basic Information
9.3.2 Pacific Biosciences Of California NGS-based RNA-seq Product Overview
9.3.3 Pacific Biosciences Of California NGS-based RNA-seq Product Market Performance
9.3.4 Pacific Biosciences Of California NGS-based RNA-seq SWOT Analysis
9.3.5 Pacific Biosciences Of California Business Overview
9.3.6 Pacific Biosciences Of California Recent Developments
9.4 Qaigen
9.4.1 Qaigen NGS-based RNA-seq Basic Information
9.4.2 Qaigen NGS-based RNA-seq Product Overview
9.4.3 Qaigen NGS-based RNA-seq Product Market Performance
9.4.4 Qaigen Business Overview
9.4.5 Qaigen Recent Developments
9.5 F. Hoffmann-La Roche
9.5.1 F. Hoffmann-La Roche NGS-based RNA-seq Basic Information
9.5.2 F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
9.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Product Market Performance
9.5.4 F. Hoffmann-La Roche Business Overview
9.5.5 F. Hoffmann-La Roche Recent Developments
9.6 Agilent Technologies
9.6.1 Agilent Technologies NGS-based RNA-seq Basic Information
9.6.2 Agilent Technologies NGS-based RNA-seq Product Overview
9.6.3 Agilent Technologies NGS-based RNA-seq Product Market Performance
9.6.4 Agilent Technologies Business Overview
9.6.5 Agilent Technologies Recent Developments
9.7 Oxford Nanopore Technologies
9.7.1 Oxford Nanopore Technologies NGS-based RNA-seq Basic Information
9.7.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
9.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Product Market Performance
9.7.4 Oxford Nanopore Technologies Business Overview
9.7.5 Oxford Nanopore Technologies Recent Developments
9.8 Perkinelmer
9.8.1 Perkinelmer NGS-based RNA-seq Basic Information
9.8.2 Perkinelmer NGS-based RNA-seq Product Overview
9.8.3 Perkinelmer NGS-based RNA-seq Product Market Performance
9.8.4 Perkinelmer Business Overview
9.8.5 Perkinelmer Recent Developments
9.9 Eurofins Scientific
9.9.1 Eurofins Scientific NGS-based RNA-seq Basic Information
9.9.2 Eurofins Scientific NGS-based RNA-seq Product Overview
9.9.3 Eurofins Scientific NGS-based RNA-seq Product Market Performance
9.9.4 Eurofins Scientific Business Overview
9.9.5 Eurofins Scientific Recent Developments
9.10 Gatc Biotech
9.10.1 Gatc Biotech NGS-based RNA-seq Basic Information
9.10.2 Gatc Biotech NGS-based RNA-seq Product Overview
9.10.3 Gatc Biotech NGS-based RNA-seq Product Market Performance
9.10.4 Gatc Biotech Business Overview
9.10.5 Gatc Biotech Recent Developments
9.11 Macrogen
9.11.1 Macrogen NGS-based RNA-seq Basic Information
9.11.2 Macrogen NGS-based RNA-seq Product Overview
9.11.3 Macrogen NGS-based RNA-seq Product Market Performance
9.11.4 Macrogen Business Overview
9.11.5 Macrogen Recent Developments
10 NGS-BASED RNA-SEQ MARKET FORECAST BY REGION
10.1 Global NGS-based RNA-seq Market Size Forecast
10.2 Global NGS-based RNA-seq Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe NGS-based RNA-seq Market Size Forecast by Country
10.2.3 Asia Pacific NGS-based RNA-seq Market Size Forecast by Region
10.2.4 South America NGS-based RNA-seq Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of NGS-based RNA-seq by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global NGS-based RNA-seq Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of NGS-based RNA-seq by Type (2025-2030)
11.1.2 Global NGS-based RNA-seq Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of NGS-based RNA-seq by Type (2025-2030)
11.2 Global NGS-based RNA-seq Market Forecast by Application (2025-2030)
11.2.1 Global NGS-based RNA-seq Sales (K Units) Forecast by Application
11.2.2 Global NGS-based RNA-seq Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. NGS-based RNA-seq Market Size Comparison by Region (M USD)
Table 5. Global NGS-based RNA-seq Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global NGS-based RNA-seq Sales Market Share by Manufacturers (2019-2024)
Table 7. Global NGS-based RNA-seq Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global NGS-based RNA-seq Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2022)
Table 10. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers NGS-based RNA-seq Sales Sites and Area Served
Table 12. Manufacturers NGS-based RNA-seq Product Type
Table 13. Global NGS-based RNA-seq Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of NGS-based RNA-seq
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NGS-based RNA-seq Market Challenges
Table 22. Global NGS-based RNA-seq Sales by Type (K Units)
Table 23. Global NGS-based RNA-seq Market Size by Type (M USD)
Table 24. Global NGS-based RNA-seq Sales (K Units) by Type (2019-2024)
Table 25. Global NGS-based RNA-seq Sales Market Share by Type (2019-2024)
Table 26. Global NGS-based RNA-seq Market Size (M USD) by Type (2019-2024)
Table 27. Global NGS-based RNA-seq Market Size Share by Type (2019-2024)
Table 28. Global NGS-based RNA-seq Price (USD/Unit) by Type (2019-2024)
Table 29. Global NGS-based RNA-seq Sales (K Units) by Application
Table 30. Global NGS-based RNA-seq Market Size by Application
Table 31. Global NGS-based RNA-seq Sales by Application (2019-2024) & (K Units)
Table 32. Global NGS-based RNA-seq Sales Market Share by Application (2019-2024)
Table 33. Global NGS-based RNA-seq Sales by Application (2019-2024) & (M USD)
Table 34. Global NGS-based RNA-seq Market Share by Application (2019-2024)
Table 35. Global NGS-based RNA-seq Sales Growth Rate by Application (2019-2024)
Table 36. Global NGS-based RNA-seq Sales by Region (2019-2024) & (K Units)
Table 37. Global NGS-based RNA-seq Sales Market Share by Region (2019-2024)
Table 38. North America NGS-based RNA-seq Sales by Country (2019-2024) & (K Units)
Table 39. Europe NGS-based RNA-seq Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific NGS-based RNA-seq Sales by Region (2019-2024) & (K Units)
Table 41. South America NGS-based RNA-seq Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa NGS-based RNA-seq Sales by Region (2019-2024) & (K Units)
Table 43. Illumina NGS-based RNA-seq Basic Information
Table 44. Illumina NGS-based RNA-seq Product Overview
Table 45. Illumina NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Illumina Business Overview
Table 47. Illumina NGS-based RNA-seq SWOT Analysis
Table 48. Illumina Recent Developments
Table 49. Thermo Fisher Scientific NGS-based RNA-seq Basic Information
Table 50. Thermo Fisher Scientific NGS-based RNA-seq Product Overview
Table 51. Thermo Fisher Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific NGS-based RNA-seq SWOT Analysis
Table 54. Thermo Fisher Scientific Recent Developments
Table 55. Pacific Biosciences Of California NGS-based RNA-seq Basic Information
Table 56. Pacific Biosciences Of California NGS-based RNA-seq Product Overview
Table 57. Pacific Biosciences Of California NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pacific Biosciences Of California NGS-based RNA-seq SWOT Analysis
Table 59. Pacific Biosciences Of California Business Overview
Table 60. Pacific Biosciences Of California Recent Developments
Table 61. Qaigen NGS-based RNA-seq Basic Information
Table 62. Qaigen NGS-based RNA-seq Product Overview
Table 63. Qaigen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Qaigen Business Overview
Table 65. Qaigen Recent Developments
Table 66. F. Hoffmann-La Roche NGS-based RNA-seq Basic Information
Table 67. F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
Table 68. F. Hoffmann-La Roche NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Agilent Technologies NGS-based RNA-seq Basic Information
Table 72. Agilent Technologies NGS-based RNA-seq Product Overview
Table 73. Agilent Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Recent Developments
Table 76. Oxford Nanopore Technologies NGS-based RNA-seq Basic Information
Table 77. Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
Table 78. Oxford Nanopore Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Oxford Nanopore Technologies Business Overview
Table 80. Oxford Nanopore Technologies Recent Developments
Table 81. Perkinelmer NGS-based RNA-seq Basic Information
Table 82. Perkinelmer NGS-based RNA-seq Product Overview
Table 83. Perkinelmer NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Perkinelmer Business Overview
Table 85. Perkinelmer Recent Developments
Table 86. Eurofins Scientific NGS-based RNA-seq Basic Information
Table 87. Eurofins Scientific NGS-based RNA-seq Product Overview
Table 88. Eurofins Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eurofins Scientific Business Overview
Table 90. Eurofins Scientific Recent Developments
Table 91. Gatc Biotech NGS-based RNA-seq Basic Information
Table 92. Gatc Biotech NGS-based RNA-seq Product Overview
Table 93. Gatc Biotech NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Gatc Biotech Business Overview
Table 95. Gatc Biotech Recent Developments
Table 96. Macrogen NGS-based RNA-seq Basic Information
Table 97. Macrogen NGS-based RNA-seq Product Overview
Table 98. Macrogen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Macrogen Business Overview
Table 100. Macrogen Recent Developments
Table 101. Global NGS-based RNA-seq Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global NGS-based RNA-seq Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America NGS-based RNA-seq Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America NGS-based RNA-seq Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe NGS-based RNA-seq Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe NGS-based RNA-seq Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific NGS-based RNA-seq Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific NGS-based RNA-seq Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America NGS-based RNA-seq Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America NGS-based RNA-seq Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa NGS-based RNA-seq Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa NGS-based RNA-seq Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global NGS-based RNA-seq Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global NGS-based RNA-seq Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global NGS-based RNA-seq Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global NGS-based RNA-seq Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global NGS-based RNA-seq Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. NGS-based RNA-seq Market Size Comparison by Region (M USD)
Table 5. Global NGS-based RNA-seq Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global NGS-based RNA-seq Sales Market Share by Manufacturers (2019-2024)
Table 7. Global NGS-based RNA-seq Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global NGS-based RNA-seq Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2022)
Table 10. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers NGS-based RNA-seq Sales Sites and Area Served
Table 12. Manufacturers NGS-based RNA-seq Product Type
Table 13. Global NGS-based RNA-seq Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of NGS-based RNA-seq
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NGS-based RNA-seq Market Challenges
Table 22. Global NGS-based RNA-seq Sales by Type (K Units)
Table 23. Global NGS-based RNA-seq Market Size by Type (M USD)
Table 24. Global NGS-based RNA-seq Sales (K Units) by Type (2019-2024)
Table 25. Global NGS-based RNA-seq Sales Market Share by Type (2019-2024)
Table 26. Global NGS-based RNA-seq Market Size (M USD) by Type (2019-2024)
Table 27. Global NGS-based RNA-seq Market Size Share by Type (2019-2024)
Table 28. Global NGS-based RNA-seq Price (USD/Unit) by Type (2019-2024)
Table 29. Global NGS-based RNA-seq Sales (K Units) by Application
Table 30. Global NGS-based RNA-seq Market Size by Application
Table 31. Global NGS-based RNA-seq Sales by Application (2019-2024) & (K Units)
Table 32. Global NGS-based RNA-seq Sales Market Share by Application (2019-2024)
Table 33. Global NGS-based RNA-seq Sales by Application (2019-2024) & (M USD)
Table 34. Global NGS-based RNA-seq Market Share by Application (2019-2024)
Table 35. Global NGS-based RNA-seq Sales Growth Rate by Application (2019-2024)
Table 36. Global NGS-based RNA-seq Sales by Region (2019-2024) & (K Units)
Table 37. Global NGS-based RNA-seq Sales Market Share by Region (2019-2024)
Table 38. North America NGS-based RNA-seq Sales by Country (2019-2024) & (K Units)
Table 39. Europe NGS-based RNA-seq Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific NGS-based RNA-seq Sales by Region (2019-2024) & (K Units)
Table 41. South America NGS-based RNA-seq Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa NGS-based RNA-seq Sales by Region (2019-2024) & (K Units)
Table 43. Illumina NGS-based RNA-seq Basic Information
Table 44. Illumina NGS-based RNA-seq Product Overview
Table 45. Illumina NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Illumina Business Overview
Table 47. Illumina NGS-based RNA-seq SWOT Analysis
Table 48. Illumina Recent Developments
Table 49. Thermo Fisher Scientific NGS-based RNA-seq Basic Information
Table 50. Thermo Fisher Scientific NGS-based RNA-seq Product Overview
Table 51. Thermo Fisher Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific NGS-based RNA-seq SWOT Analysis
Table 54. Thermo Fisher Scientific Recent Developments
Table 55. Pacific Biosciences Of California NGS-based RNA-seq Basic Information
Table 56. Pacific Biosciences Of California NGS-based RNA-seq Product Overview
Table 57. Pacific Biosciences Of California NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pacific Biosciences Of California NGS-based RNA-seq SWOT Analysis
Table 59. Pacific Biosciences Of California Business Overview
Table 60. Pacific Biosciences Of California Recent Developments
Table 61. Qaigen NGS-based RNA-seq Basic Information
Table 62. Qaigen NGS-based RNA-seq Product Overview
Table 63. Qaigen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Qaigen Business Overview
Table 65. Qaigen Recent Developments
Table 66. F. Hoffmann-La Roche NGS-based RNA-seq Basic Information
Table 67. F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
Table 68. F. Hoffmann-La Roche NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Agilent Technologies NGS-based RNA-seq Basic Information
Table 72. Agilent Technologies NGS-based RNA-seq Product Overview
Table 73. Agilent Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Recent Developments
Table 76. Oxford Nanopore Technologies NGS-based RNA-seq Basic Information
Table 77. Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
Table 78. Oxford Nanopore Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Oxford Nanopore Technologies Business Overview
Table 80. Oxford Nanopore Technologies Recent Developments
Table 81. Perkinelmer NGS-based RNA-seq Basic Information
Table 82. Perkinelmer NGS-based RNA-seq Product Overview
Table 83. Perkinelmer NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Perkinelmer Business Overview
Table 85. Perkinelmer Recent Developments
Table 86. Eurofins Scientific NGS-based RNA-seq Basic Information
Table 87. Eurofins Scientific NGS-based RNA-seq Product Overview
Table 88. Eurofins Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eurofins Scientific Business Overview
Table 90. Eurofins Scientific Recent Developments
Table 91. Gatc Biotech NGS-based RNA-seq Basic Information
Table 92. Gatc Biotech NGS-based RNA-seq Product Overview
Table 93. Gatc Biotech NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Gatc Biotech Business Overview
Table 95. Gatc Biotech Recent Developments
Table 96. Macrogen NGS-based RNA-seq Basic Information
Table 97. Macrogen NGS-based RNA-seq Product Overview
Table 98. Macrogen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Macrogen Business Overview
Table 100. Macrogen Recent Developments
Table 101. Global NGS-based RNA-seq Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global NGS-based RNA-seq Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America NGS-based RNA-seq Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America NGS-based RNA-seq Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe NGS-based RNA-seq Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe NGS-based RNA-seq Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific NGS-based RNA-seq Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific NGS-based RNA-seq Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America NGS-based RNA-seq Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America NGS-based RNA-seq Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa NGS-based RNA-seq Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa NGS-based RNA-seq Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global NGS-based RNA-seq Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global NGS-based RNA-seq Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global NGS-based RNA-seq Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global NGS-based RNA-seq Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global NGS-based RNA-seq Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of NGS-based RNA-seq
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NGS-based RNA-seq Market Size (M USD), 2019-2030
Figure 5. Global NGS-based RNA-seq Market Size (M USD) (2019-2030)
Figure 6. Global NGS-based RNA-seq Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NGS-based RNA-seq Market Size by Country (M USD)
Figure 11. NGS-based RNA-seq Sales Share by Manufacturers in 2023
Figure 12. Global NGS-based RNA-seq Revenue Share by Manufacturers in 2023
Figure 13. NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by NGS-based RNA-seq Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global NGS-based RNA-seq Market Share by Type
Figure 18. Sales Market Share of NGS-based RNA-seq by Type (2019-2024)
Figure 19. Sales Market Share of NGS-based RNA-seq by Type in 2023
Figure 20. Market Size Share of NGS-based RNA-seq by Type (2019-2024)
Figure 21. Market Size Market Share of NGS-based RNA-seq by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global NGS-based RNA-seq Market Share by Application
Figure 24. Global NGS-based RNA-seq Sales Market Share by Application (2019-2024)
Figure 25. Global NGS-based RNA-seq Sales Market Share by Application in 2023
Figure 26. Global NGS-based RNA-seq Market Share by Application (2019-2024)
Figure 27. Global NGS-based RNA-seq Market Share by Application in 2023
Figure 28. Global NGS-based RNA-seq Sales Growth Rate by Application (2019-2024)
Figure 29. Global NGS-based RNA-seq Sales Market Share by Region (2019-2024)
Figure 30. North America NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America NGS-based RNA-seq Sales Market Share by Country in 2023
Figure 32. U.S. NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada NGS-based RNA-seq Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico NGS-based RNA-seq Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe NGS-based RNA-seq Sales Market Share by Country in 2023
Figure 37. Germany NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 43. Asia Pacific NGS-based RNA-seq Sales Market Share by Region in 2023
Figure 44. China NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 50. South America NGS-based RNA-seq Sales Market Share by Country in 2023
Figure 51. Brazil NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa NGS-based RNA-seq Sales Market Share by Region in 2023
Figure 56. Saudi Arabia NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global NGS-based RNA-seq Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global NGS-based RNA-seq Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global NGS-based RNA-seq Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global NGS-based RNA-seq Market Share Forecast by Type (2025-2030)
Figure 65. Global NGS-based RNA-seq Sales Forecast by Application (2025-2030)
Figure 66. Global NGS-based RNA-seq Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of NGS-based RNA-seq
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NGS-based RNA-seq Market Size (M USD), 2019-2030
Figure 5. Global NGS-based RNA-seq Market Size (M USD) (2019-2030)
Figure 6. Global NGS-based RNA-seq Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NGS-based RNA-seq Market Size by Country (M USD)
Figure 11. NGS-based RNA-seq Sales Share by Manufacturers in 2023
Figure 12. Global NGS-based RNA-seq Revenue Share by Manufacturers in 2023
Figure 13. NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by NGS-based RNA-seq Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global NGS-based RNA-seq Market Share by Type
Figure 18. Sales Market Share of NGS-based RNA-seq by Type (2019-2024)
Figure 19. Sales Market Share of NGS-based RNA-seq by Type in 2023
Figure 20. Market Size Share of NGS-based RNA-seq by Type (2019-2024)
Figure 21. Market Size Market Share of NGS-based RNA-seq by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global NGS-based RNA-seq Market Share by Application
Figure 24. Global NGS-based RNA-seq Sales Market Share by Application (2019-2024)
Figure 25. Global NGS-based RNA-seq Sales Market Share by Application in 2023
Figure 26. Global NGS-based RNA-seq Market Share by Application (2019-2024)
Figure 27. Global NGS-based RNA-seq Market Share by Application in 2023
Figure 28. Global NGS-based RNA-seq Sales Growth Rate by Application (2019-2024)
Figure 29. Global NGS-based RNA-seq Sales Market Share by Region (2019-2024)
Figure 30. North America NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America NGS-based RNA-seq Sales Market Share by Country in 2023
Figure 32. U.S. NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada NGS-based RNA-seq Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico NGS-based RNA-seq Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe NGS-based RNA-seq Sales Market Share by Country in 2023
Figure 37. Germany NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 43. Asia Pacific NGS-based RNA-seq Sales Market Share by Region in 2023
Figure 44. China NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 50. South America NGS-based RNA-seq Sales Market Share by Country in 2023
Figure 51. Brazil NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa NGS-based RNA-seq Sales Market Share by Region in 2023
Figure 56. Saudi Arabia NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa NGS-based RNA-seq Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global NGS-based RNA-seq Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global NGS-based RNA-seq Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global NGS-based RNA-seq Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global NGS-based RNA-seq Market Share Forecast by Type (2025-2030)
Figure 65. Global NGS-based RNA-seq Sales Forecast by Application (2025-2030)
Figure 66. Global NGS-based RNA-seq Market Share Forecast by Application (2025-2030)
